Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Ecolomondo Corp
Harmony Biosciences Holdings, Inc. - Common Stock
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zivo Bioscience, Inc. - Common Stock
(NQ:
ZIVO
)
N/A
UNCHANGED
Last Price
Updated: 1:00 PM EST, Nov 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zivo Bioscience, Inc. - Common Stock
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
February 07, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
January 23, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
October 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Announces Reverse Stock Split
October 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
October 03, 2023
From
Zivo Bioscience, Inc.
Via
GlobeNewswire
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
September 19, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
August 16, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
July 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
June 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Receives $1 Million Bridge Financing
April 05, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
February 10, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
October 24, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience CEO Issues Letter to Shareholders
September 23, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
August 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Zivo Bioscience Joins Russell Microcap® Index
June 27, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
April 25, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
January 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
